Результаты поиска

Transformative Impact of Nanocarrier-Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons.

Advancing therapeutic progress is centered on developing drug delivery systems (DDS) that control therapeutic molecule release, ensuring precise targeting and optimal concentrations. Targeted DDS enhances treatment efficacy and minimizes off-target effects, but struggles with drug degradation. Over the last three decades, nanopharmaceuticals have evolved from laboratory concepts into clinical products, highlighting the profound impact of nanotechnology in medicine. Despite advancements, the effective delivery of therapeutics remains challenging because of biological barriers. Nanocarriers offe

Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines).

The Coronavirus disease (COVID-19) pandemic is disrupting our health environment. As expected, studies highlighted the great susceptibility of cancer patients to COVID-19 and more severe complications, leading oncologists to deeply rethink patient cancer care. This review is dedicated to the optimization of care pathways and therapeutics in cancer patients during the pandemic and aims to discuss successive issues. First we focused on the international guidelines proposing adjustments and alternative options to cancer care in order to limit hospital admission and cytopenic treatment in cancer p

Совпадение в полном тексте источника
… Interferon beta-1a Interferon beta-1a is indicated in multiple sclerosis and is evaluated in DisCoVeRy trial at 44 µg at days 1, 3 and 6. It shows a very favorable interaction profile, with no cytochrome- or transporter-mediated effects. …

Множественный склероз и кишечная микробиота: Lachnospiraceae из подлеца близнецов MS вызывает заболевание, похожее на MS, в бесфинансовом трансгенном мыше-Непредвзятом функциональном исследовании.

Мы разработали двухуровневую стратегию, направленную на выявление кишечных бактерий, функционально связанных с развитием множественного склероза (MS). Во-первых, мы сравнили кишечные микробные профили в группе из 81 монозиготных близнецов, которые расходятся с MS. Такой подход позволил свести к минимуму смешанное воздействие генетических и ранних экологических факторов и выявил более 50 различных таксов, при этом большинство повышенных таксонов внутри фирм. К ним относятся такса, ранее описываемая как ассоциированная с MS (Anaerotruncus colihominis и Eisenbergiella Tayi), а также вновь выявлен

Совпадение в аннотации оригинала
We developed a two-tiered strategy aiming to identify gut bacteria functionally linked to the development of multiple sclerosis (MS). First, we compared gut microbial profiles in a cohort of 81 monozygotic twins discordant for MS. This approach allowed to minimize confounding effects by genetic and early environmental factors and identified over 50 different…

Физические упражнения низкой интенсивности связаны с улучшением мелиорации и сокращением микрогранной активации в модели обезвоживания Cuprizone.

Уничтожение таких болезней, как множественный склероз, приводит к повреждению милиновой оболочки, что приводит к неврологическим проблемам. Хотя точные причины НР неясны, известно, что подстрекательские процессы и плохое воспоминание способствуют прогрессированию заболеваний. Упражнения показали, что они являются ненаркотической терапией для MS, и, согласно сообщениям, выгоды для мобильности, настроения и потенциальной нейрозащиты. Однако не в полной мере понимаются конкретные способы воздействия физических упражнений на воспоминание и нейронное воспаление в условиях демиелина. В рамках этого

Совпадение в аннотации оригинала
Demyelinating diseases like multiple sclerosis cause damage to the myelin sheath, leading to neurological problems. While the exact causes of MS are unclear, it is known that inflammatory processes and poor remyelination contribute to disease progression. Exercise has shown promise as a non-drug treatment for MS, with benefits reported for mobility, mood, an…

Galectin-9 - ligand axis: an emerging therapeutic target for multiple myeloma.

Galectin-9 (Gal-9) is a tandem-repeat galectin with diverse roles in immune homeostasis, inflammation, malignancy, and autoimmune diseases. In cancer, Gal-9 displays variable expression patterns across different tumor types. Its interactions with multiple binding partners, both intracellularly and extracellularly, influence key cellular processes, including immune cell modulation and tumor microenvironment dynamics. Notably, Gal-9 binding to cell-specific glycoconjugate ligands has been implicated in both promoting and suppressing tumor progression. Here, we provide insights into Gal-9 and its

Совпадение в полном тексте источника
… Dysregulated T cell expression of TIM3 in multiple sclerosis . J Exp Med . ( 2006 ) 203 : 1413–8 . doi: 10.1084/jem.20060210 PMC2118310 16754722 59 Nishi N Itoh A Shoji H Miyanaka H Nakamura T . Galectin-8 and galectin-9 are novel substrates for thrombin . …

Redox Remodeling by Nutraceuticals for Prevention and Treatment of Acute and Chronic Inflammation.

Antioxidant-rich dietary regimens are considered the best practice to maintain health, control inflammation, and prevent inflammatory diseases. Yet, nutraceuticals as food supplements are self-prescribed and purchasable over the counter by healthy individuals for the purpose of beneficial effects on fitness and aging. Hence, the effectiveness, safety, and correct intake of these compounds need to be better explored. Since redox-modulating activity of these compounds appears to be involved in activation and or suppression of immune cells, the preventive use of nutraceuticals is very attractive

Совпадение в полном тексте источника
… Furthermore, in multiple sclerosis, induction of Nrf2 promotes Treg cell differentiation and survival and reduction of symptoms. …

Myokines in cancer: bridging molecular mechanisms to biomarker discovery and therapeutic innovation.

Exercise can regulate the physiological functions of the body by inducing the secretion of myokines, which are bioactive factors mainly secreted by muscle cells. This review classifies myokines based on their functional characteristics, including metabolic regulation (such as myostatin, interleukin-6), neuroregulation (brain-derived neurotrophic factor), cell proliferation/differentiation regulation (myogenic proteins), immune regulation (tumor necrosis factor- alpha), and factors involved in angiogenesis and extracellular matrix remodeling (such as connective tissue growth factor).Cancer, as

Совпадение в полном тексте источника
… The relevance of BDNF for neuroprotection and neuroplasticity in multiple sclerosis. Front Neurol. (2024) 15:1385042. doi: 10.3389/fneur.2024.1385042, PMID: 19. Tettamanti G, Cattaneo AG, Gornati R, De Eguileor M, Bernardini G, Binelli G. …

Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications.

Reactive oxygen species (ROS) act as critical secondary messengers in various intracellular signaling pathways that regulate cellular proliferation, differentiation, and survival under normal physiological conditions. However, dysregulation of redox signaling-driven by genetic mutations, epigenetic alterations, and posttranscriptional or posttranslational modifications-plays a central role in malignant transformation and cancer progression. Cancer cells typically exhibit elevated basal ROS levels due to increased metabolic activity, mitochondrial dysfunction, and oncogene activation. This mode

Precision Reimbursement for Precision Medicine: Using Real-World Evidence to Evolve From Trial-and-Project to Track-and-Pay to Learn-and-Predict.

Basic scientists and drug developers are accelerating innovations toward the goal of precision medicine. Regulators create pathways for timely patient access to precision medicines, including individualized therapies. Healthcare payors acknowledge the need for change but downstream innovation for coverage and reimbursement is only haltingly occurring. Performance uncertainty, high price-tags, payment timing, and actuarial risk issues associated with precision medicines present novel financial challenges for payors. With traditional drug reimbursement frameworks, payment is based on an assumed

Совпадение в полном тексте источника
… One of the first and most controversial attempts at track‐and‐pay was the “UK multiple sclerosis risk sharing” arrangement, set up almost 20 years ago by the UK National Health Service. 23 The scheme ran into a number of problems, was not generally considered a success, and raised the issue whether a …

Antibodies to watch in 2026.

The Antibodies to Watch article series provides annual updates on commercial late-stage clinical development, regulatory review, and marketing approvals of antibody therapeutics. Since the first article was published in 2010, the late-stage pipeline has grown from 26 antibody therapeutics to over 200, while during the same time numerous molecules in late-stage studies either transitioned to regulatory review and were approved or were terminated. In this installment of the series, we recap first marketing approvals granted to 19 antibody therapeutics in 2025, discuss 26 molecules currently in r

Поддержка со стороны сверстников в хронических условиях с точки зрения сверстников: систематический обзор.

Цель: Поддержка со стороны сверстников может стать ценным дополнением к обычному уходу за пациентами с хроническими заболеваниями. Хотя выгоды, связанные с поддержкой со стороны сверстников, хорошо задокументированы, в большинстве исследований основное внимание уделяется интересам получателей помощи. Учитывая центральную роль, которую играют сторонники из числа сверстников, их опыт следует рассматривать как не менее важный. В рамках этого систематического обзора обобщается имеющаяся литература, посвященная опыту сочувствующих друг другу лиц с хроническими заболеваниями. Метод: Мы проводили сис

Совпадение в полном тексте источника
… Other areas of conditions were cardiovascular disease, deafness, multiple sclerosis, aphasia, renal disease, stroke and traumatic brain injury. Three records reported on disease unspecific interventions for chronic conditions. …

Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis.

Chemotherapy-induced peripheral neuropathy (CIPN) is the most common neurologic complication of chemotherapy, resulting in symptoms like pain, sensory loss, and numbness in the hands and feet that cause lots of uneasiness in patients with cancer. They often suffer from pain so severe that it interrupts the treatment, thus invalidating the entire chemotherapy-based healing process, and significantly reducing their quality of life. In this paper, we underline the role of the complement system in CIPN, highlighting the relevance of the C5a fragment and its receptor C5aR1, whose activation is thou

Совпадение в полном тексте источника
… Furthermore, the role of the C5a/C5aR axis in pathological conditions [ 122 , 148 , 149 ] such as rheumatoid arthritis [ 150 ], sepsis [ 151 ], autoimmune disorders [ 152 ], multiple sclerosis and Alzheimer’s disease [ 153 ] was investigated. …

Экспериментальный аутоиммунный энцефаломиэлит патогенез меняется в зависимости от возраста животных: воздействие выражения S100B.

Множественный склероз (MS) является основной провокационной и нетравматической причиной инвалидности среди молодых людей, при этом у пациентов среднего возраста часто появляются поздние МБ, что приводит к более слабому лечению и худшим прогнозам. Протеина S100B, связывающего кальций, выше у пациентов с сеток, и ее целевая направленность показала, что в экспериментальных моделях аутоиммунного энцефаломиелита (EAE) она может снизить остроту заболеваний. Однако в большинстве исследований по патологии MS основное внимание уделяется моделям молодого животного, что оставляет пробел в понимании возде

Совпадение в аннотации оригинала
Multiple Sclerosis (MS) is the leading inflammatory and non-traumatic cause of disability in young adults, with late-onset MS emerging in middle-aged patients often resulting in poorer treatment responses and worse prognoses. The calcium-binding protein S100B is elevated in MS patients, and its targeting has shown promise in reducing disease severity in expe…

Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations.

Inflammatory bowel disease (IBD) management traditionally focuses on intestinal inflammation, yet extraintestinal manifestations can substantially impair patient quality of life. In this perspective, we emphasize the broad systemic impact of IBD-from highly prevalent conditions such as anemia, metabolic dysfunction-associated steatotic liver disease, or fatigue to rare but severe complications like interstitial lung disease and drug-induced glomerulonephritis. We review underlying mechanisms linking gut inflammation to distant organs, including immune dysregulation, microbial translocation, an

Совпадение в полном тексте источника
… Demyelinating Diseases Patients with IBD exhibit increased risk of central demyelinating disorders, including multiple sclerosis (MS) and isolated optic neuritis, with pooled hazard ratio of 1.54 for MS [ 27 ]. …

Liver Disease Associated with Non-Hepatitis Viruses

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… Clinical presentation The full spectrum of diseases caused by chronic HHV-6 and -7 infection is still unclear, but these viruses are putatively involved in a variety of different syndromes such as encephalitis, multiple sclerosis, pneumonitis, an infectious mononucleosis-like syndrome, postinfectious …

Резюме докладов 38th - ежегодное собрание общества общей внутренней медицины.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Recent Insights in Multi-Target Drugs in Pharmacology and Medicinal Chemistry.

Many of the drugs used in treatment today have been designed based on the "specificity paradigm". Resistance has developed against drugs designed using this approach, leading to a decrease in their effectiveness. In addition, it is well-documented in the literature that diseases with complex etiologies, such as Alzheimer's, Parkinson's, and cancer are influenced by multiple genetic and/or environmental factors. As a result, specificity paradigm is often insufficient for treating these diseases. Therefore, there is a need to develop drugs that interact with multiple targets simultaneously throu

Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology.

The acute and long-lasting side effects of modern multimodal tumour therapy significantly impair quality of life and survival of patients afflicted with malignancies. The key components of this therapy include radiotherapy, conventional chemotherapy, immunotherapy and targeted therapies. In addition to established tumour therapy strategies, up to 30 new therapies are approved each year with only incompletely characterised side effects. This consensus paper discusses the risk factors that contribute to the development of a potentially adverse reaction to tumour therapy and, in addition, defines

Nanoparticle-based strategy in CAR-T cell immunotherapy: challenges, implications, and perspectives.

Chimeric antigen receptor (CAR)-T cell therapy has achieved remarkable progress in treating hematologic malignancies, yet its broader application faces challenges such as manufacturing complexity, solid tumor microenvironment barriers, and immune toxicity. Nanoparticles (NPs), leveraging their precise delivery, immunomodulation, and multifunctional integration capabilities, offer innovative strategies to optimize CAR-T cell therapy. This review provides a comprehensive elucidation of the fundamental framework of CAR-T cell therapy and the challenges in oncological applications. Subsequently, w

Patient-reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review.

IntroductionAdoptive cell therapy (ACT) is a rapidly evolving field. Patient-reported outcomes (PROs) allow patients to report the impact of treatment on their quality of life during and after treatment. The systematic review aims to characterise the breadth of PROs utilised in ACT cancer care and provide guidance for the use of PROs in this patient population in the future.MethodsA systematic search was conducted (MEDLINE, PsycINFO, Embase and CINAHL) in August 2021 by two reviewers. Search terms covered the following: "adoptive cell therapy", "patient-reported outcomes" and "cancer". Studies

Совпадение в полном тексте источника
… Thresholds for severity of four Neuro-QoL measures (fatigue, upper extremity function, lower extremity function-mobility, sleep disturbance) have been estimated using a modified bookmarking methodology based on the perspective of individuals with multiple sclerosis and clinicians | Disease specific ( …